Zobrazeno 1 - 10
of 157
pro vyhledávání: '"Andrea, Palicelli"'
Autor:
Francesca Sanguedolce, Ugo Giovanni Falagario, Magda Zanelli, Andrea Palicelli, Maurizio Zizzo, Stefano Ascani, Simona Tortorella, Gian Maria Busetto, Angelo Cormio, Giuseppe Carrieri, Luigi Cormio
Publikováno v:
Current Issues in Molecular Biology, Vol 46, Iss 3, Pp 2456-2467 (2024)
There is an ongoing need for biomarkers that could reliably predict the outcome of BC and that could guide the management of this disease. In this setting, we aimed to explore the prognostic value of the transcription factor P63 in patients with musc
Externí odkaz:
https://doaj.org/article/bcb0ce77d14d4a2788e4ded6437572b8
Autor:
Eleonora Cabitza, Marta Pirola, Cinzia Baldessari, Giuditta Bernardelli, Elena Zunarelli, Stefania Pipitone, Maria Giuseppa Vitale, Cecilia Nasso, Eleonora Molinaro, Marco Oltrecolli, Elisa D’Agostino, Vincenzo Dario Mandato, Andrea Palicelli, Massimo Dominici, Roberto Sabbatini
Publikováno v:
Journal of Medical Case Reports, Vol 17, Iss 1, Pp 1-5 (2023)
Abstract Background Ovarian cancer is metastatic at presentation in about 62% of cases, but brain metastases are rare, reported in 3.3–4% of patients. Brain metastasis seems to be more frequent in advanced stages at diagnosis and in patients with B
Externí odkaz:
https://doaj.org/article/a4f5a6c85c3d401a928fbbcb6aa4d4bf
Autor:
Nektarios I. Koufopoulos, Ioannis Boutas, Abraham Pouliakis, Menelaos G. Samaras, Christakis Kotanidis, Adamantia Kontogeorgi, Dionysios T. Dimas, Argyro-Ioanna Ieronimaki, Danai Leventakou, Aris Spathis, Magda Zanelli, Andrea Palicelli, Maurizio Zizzo, Dimitrios Goutas, Ioannis S. Pateras, Ioannis G. Panayiotides
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 15, p 8382 (2024)
Breast carcinoma is the most common cancer in women. Nineteen different subtypes of breast carcinomas are recognized in the current WHO classification of breast tumors. Except for these subtypes, there are a number of carcinomas with special morpholo
Externí odkaz:
https://doaj.org/article/e7cd467c0e7b48d3a0a94963f995f23e
Autor:
Lucia Mangone, Francesco Marinelli, Isabella Bisceglia, Angelina Filice, Maria Barbara Braghiroli, Francesca Roncaglia, Andrea Palicelli, Fortunato Morabito, Antonino Neri, Roberto Sabbatini, Cinzia Iotti, Carmine Pinto
Publikováno v:
Biology, Vol 13, Iss 7, p 499 (2024)
The COVID-19 pandemic has caused delays in cancer diagnoses and reductions in treatments. The aim of this work is to evaluate the impact of the pandemic on prostate cancer by evaluating whether there has been a shift towards more aggressive (Gleason)
Externí odkaz:
https://doaj.org/article/4b29f2c1aea74b41ab7fe97a66604e90
Autor:
Magda Zanelli, Valentina Fragliasso, Giuseppe Gaetano Loscocco, Francesca Sanguedolce, Giuseppe Broggi, Maurizio Zizzo, Andrea Palicelli, Stefano Ricci, Elisa Ambrogi, Giovanni Martino, Sara Aversa, Francesca Coppa, Pietro Gentile, Fabrizio Gozzi, Rosario Caltabiano, Nektarios Koufopoulos, Aleksandra Asaturova, Luca Cimino, Alberto Cavazza, Giulio Fraternali Orcioni, Stefano Ascani
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 12 (2024)
Myeloproliferative neoplasms (MPNs) are subdivided into Philadelphia (Ph) chromosome-positive chronic myeloid leukemia (CML) and Ph-negative MPNs. BCR::ABL1 translocation is essential for the development and diagnosis of CML; on the other hand, the m
Externí odkaz:
https://doaj.org/article/4fe0b9b39cf248c7a452aedee928a312
Autor:
Magda Zanelli, Alessandra Bisagni, Francesca Sanguedolce, Giuseppe Broggi, Valentina Fragliasso, Maurizio Zizzo, Andrea Palicelli, Giovanni Martino, Camilla Cresta, Cecilia Caprera, Matteo Corsi, Pietro Gentile, Fabrizio Gozzi, Domenico Trombetta, Paola Parente, Rosario Caltabiano, Nektarios Koufopoulos, Luca Cimino, Alberto Cavazza, Giulio Fraternali Orcioni, Stefano Ascani
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
Myeloproliferative neoplasms (MPNs) are classified into Philadelphia (Ph) chromosome–positive chronic myeloid leukemia (CML) and Ph-negative MPNs. BCR::ABL1 translocation is the key genetic event of CML, whereas JAK2/MPL/CALR mutations are molecula
Externí odkaz:
https://doaj.org/article/1924b8d25e974aeb9c284d5a0038f77c
Autor:
Gabriele Tonni, Andrea Palicelli, Maria Chiara Bassi, Federica Torricelli, Ilaria Vacca, Lorenzo Aguzzoli, Vincenzo Dario Mandato
Publikováno v:
Cancers, Vol 16, Iss 13, p 2305 (2024)
Background: Gastrointestinal stromal tumors (GISTs) are a rare neoplasm, sometimes mimicking primary ovarian tumors (OTs) and/or metastasizing to the ovaries (M-OT). We performed a systematic literature review (SLR) of OTs and M-OTs, investigating di
Externí odkaz:
https://doaj.org/article/814a619b454d463f8b5145fd87d5a118
Publikováno v:
Cancers, Vol 16, Iss 13, p 2322 (2024)
According to recent reports, ovarian serous borderline tumor (SBT) harboring the BRAF V600E mutation is associated with a lower risk of progression to low-grade serous carcinoma. Preliminary observations suggest that there may be an association betwe
Externí odkaz:
https://doaj.org/article/21bb66fd5e604b81b3f7db941a72a05c
Autor:
Magda Zanelli, Valentina Fragliasso, Paola Parente, Alessandra Bisagni, Francesca Sanguedolce, Maurizio Zizzo, Giuseppe Broggi, Stefano Ricci, Andrea Palicelli, Moira Foroni, Fabrizio Gozzi, Pietro Gentile, Andrea Morini, Nektarios Koufopoulos, Rosario Caltabiano, Luca Cimino, Massimiliano Fabozzi, Alberto Cavazza, Antonino Neri, Stefano Ascani
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 12, p 6447 (2024)
The interaction of programmed death-1 (PD-1) on T lymphocytes with its ligands Programmed Death Ligand 1 (PD-L1) and Programmed Death Ligand 2 (PD-L2) on tumor cells and/or tumor-associated macrophages results in inhibitory signals to the T-cell rece
Externí odkaz:
https://doaj.org/article/d86fea92745f4c5280b038198e30419e
Autor:
Francesca Sanguedolce, Roberta Mazzucchelli, Ugo Giovanni Falagario, Angelo Cormio, Magda Zanelli, Andrea Palicelli, Maurizio Zizzo, Albino Eccher, Matteo Brunelli, Andrea Benedetto Galosi, Giuseppe Carrieri, Luigi Cormio
Publikováno v:
Cancers, Vol 16, Iss 10, p 1856 (2024)
The fifth edition of the World Health Organization (WHO) classification for urogenital tumors, released in 2022, introduces some novelties in the chapter on renal epithelial tumors compared to the previous 2016 classification. Significant changes inc
Externí odkaz:
https://doaj.org/article/bbfff0029612442e9ca6026546c2f6b8